Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery

被引:82
|
作者
Kheterpal, Sachin [1 ]
Khodaparast, Omeed [2 ]
Shanks, Amy [1 ]
O'Reilly, Michael [1 ]
Tremper, Kevin K. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48103 USA
[2] Baylor Univ, Med Ctr, Dept Anesthesiol, Dallas, TX 75246 USA
关键词
angiotensin-converting enzyme inhibitor; intraoperative hypotension; diuretics;
D O I
10.1053/j.jvca.2007.12.020
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Chronic angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) therapy has been reported to result in intraoperative hypotension in patients undergoing general anesthesia. This study evaluated the association between ACE-I/ARB therapy and the hemodynamics of patients undergoing noncardiac surgery using a large patient dataset. Design and Setting: A prospective, observational study performed at a single tertiary care hospital. Participants: All adult patients undergoing noncardiac surgery. Interventions: None. Measurements and Main Results: Propensity score matching for the likelihood of chronic ACE-I/ARB therapy was used to create 2 patient cohorts with similar cardiovascular and pulmonary comorbidities. The number of periods of absolute and relative hypotension, vasopressor requirements, and postoperative myocardial infarction and renal failure rates were compared among patients with and without ACE-I/ARB therapy. A total of 65,043 noncardiac cases be-tween 2003 and 2006 were included. Two-digit propensity score matching resulted in a study population of 12,381 operative cases with very similar cardiovascular comorbidities between the ACE-I/ARB and control cohort. Patients with chronic ACE-I/ARB and diuretic therapy showed more periods with a mean arterial pressure <70 mmHg, periods with a 40% decrease in systolic blood pressure, periods with a 50% decrease in systolic blood pressure, and vasopressor boluses when compared with patients with diuretic therapy alone. There were no statistically significant differences in the rates of postoperative myocardial infarction or renal failure between patients with and without ACE-I/ARB therapy. Conclusions: Chronic diuretic therapy is associated with more frequent hypotension in ACE-I/ARB-treated patients undergoing noncardiac surgery. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [41] Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention
    Ann, Soe Hee
    Strauss, Martin H.
    Park, Gyung-Min
    Han, Seungbong
    Yang, Yujin
    Kim, Yong-Giun
    Won, Ki-Bum
    Kim, Shin-Jae
    Lee, Sang-Gon
    Cho, Young-Rak
    Kim, Dae-Won
    Park, Mahn-Won
    Her, Sung Ho
    Lee, Seung-Whan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 35 - 41
  • [42] Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor
    Sleight, Peter
    JOURNAL OF HYPERTENSION, 2009, 27 : S23 - S29
  • [43] Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient
    Jarred, Ghassan
    Kennedy, R. Lee
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2010, 1 (01) : 23 - 28
  • [44] Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria
    Chu, Chi D.
    Powe, Neil R.
    McCulloch, Charles E.
    Banerjee, Tanushree
    Crews, Deidra C.
    Saran, Rajiv
    Bragg-Gresham, Jennifer
    Morgenstern, Hal
    Pavkov, Meda E.
    Saydah, Sharon H.
    Tuot, Delphine S.
    HYPERTENSION, 2021, 77 (01) : 94 - 102
  • [45] Clinical Value of Angiotensin-converting Enzyme Inhibitor and Angiotensin Receptor Blocker in the Patients of Coronary Artery Disease
    Abe, Daisuke
    Sato, Akira
    Misaki, Masako
    Takeyasu, Noriyuki
    Hoshi, Tomoya
    Aonuma, Kazutaka
    CIRCULATION, 2013, 128 (22)
  • [46] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    G Bönner
    G L Bakris
    D Sica
    M A Weber
    W B White
    A Perez
    C Cao
    A Handley
    S Kupfer
    Journal of Human Hypertension, 2013, 27 : 479 - 486
  • [47] Can an Angiotensin Receptor Blocker Be Used in a Patient in Whom Angioedema Developed With an Angiotensin-Converting Enzyme Inhibitor?
    Cohen, Debbie L.
    Townsend, Raymond R.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (12): : 949 - 950
  • [48] Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
    Rossato, Marco
    Di Vincenzo, Angelo
    EUROPEAN CARDIOLOGY REVIEW, 2020, 15
  • [49] Combination therapy with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker with early statin administration in patients admitted to a coronary unit for unstable angina
    Gabrielyan, R. S.
    Davtyan, A. V.
    Gabrielyan, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 567 - 567
  • [50] Angiotensin-converting enzyme inhibitor/angiotensin receptor blockade therapy in subjects with symptomatic hypotension: Experience of a community disease management program for heart failure
    Akosah, Kwame O.
    Vig, Mark E.
    McHugh, Vicki L.
    Mathiason, Michelle A.
    CIRCULATION, 2007, 115 (08) : E253 - E253